Table of Contents
NASHVILLE – Crown Laboratories announced Wednesday that it will operate under the name Revance, effective immediately.
This change marks a significant milestone in the company’s strategic transformation following its recent acquisition of Revance Therapeutics, Inc., a biotechnology company known for its cutting edge innovation in aesthetics and therapeutics, which joins Crown’s deep roots in science-driven brands for skin health and rejuvenation.
Bill Schiffner
“The transition to the Revance name marks an exciting new chapter for our company, representing the future of our combined portfolio of advanced, science-driven brands that are designed to address the ever-changing needs of patients, clinicians, and consumers worldwide,” said Jeff Bedard, CEO of Revance.
Revance was chosen as the name that best represents the newly combined company mission to revolutionize the aesthetics and skincare industry through science-based, innovative products.
Bedard continued, “By uniting our complementary market-leading products and incredibly talented teams under one powerful brand, we are strengthening our unique position in the marketplace and unlocking exciting new opportunities for growth. Importantly, our dedication to excellence, innovation, and serving our customers remains unchanged. We look forward to continuing to execute on our successful integration and go-forward strategy, as we aim to become a global leader in injectables, skin quality and skincare solutions.”
